These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 1357578)
1. Effect of noradrenergic denervation by neonatal DSP-4 on peptide neurotransmitter systems in the rat brain. Donnerer J; Humpel C; Saria A Neuropeptides; 1992 Jun; 22(2):103-6. PubMed ID: 1357578 [TBL] [Abstract][Full Text] [Related]
2. Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment. Harro J; Jossan SS; Oreland L Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):425-31. PubMed ID: 1436127 [TBL] [Abstract][Full Text] [Related]
3. Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat. Jonsson G; Hallman H; Sundström E Neuroscience; 1982; 7(11):2895-907. PubMed ID: 7155358 [TBL] [Abstract][Full Text] [Related]
4. Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study. Lategan AJ; Marien MR; Colpaert FC Life Sci; 1992; 50(14):995-9. PubMed ID: 1372673 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats. Srinivasan J; Schmidt WJ Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465 [TBL] [Abstract][Full Text] [Related]
6. Studies on brain monoamine and neuropeptide systems after neonatal intracerebroventricular 6-hydroxydopamine treatment. Luthman J; Brodin E; Sundström E; Wiehager B Int J Dev Neurosci; 1990; 8(5):549-60. PubMed ID: 1704172 [TBL] [Abstract][Full Text] [Related]
7. Effects of the noradrenaline neurotoxin DSP 4 on monoamine neurons and their transmitter turnover in rat CNS. Hallman H; Sundström E; Jonsson G J Neural Transm; 1984; 60(2):89-102. PubMed ID: 6208323 [TBL] [Abstract][Full Text] [Related]
8. Selective Lifelong Destruction of Brain Monoaminergic Nerves Through Perinatal DSP-4 Treatment. Nowak P Curr Top Behav Neurosci; 2016; 29():51-71. PubMed ID: 26427851 [TBL] [Abstract][Full Text] [Related]
9. Involvement of the paraventricular (PVN) and arcuate (ARC) nuclei of the hypothalamus in the central noradrenergic regulation of liver cytochrome P450. Bromek E; Wójcikowski J; Daniel WA Biochem Pharmacol; 2013 Dec; 86(11):1614-20. PubMed ID: 24051135 [TBL] [Abstract][Full Text] [Related]
10. Effect of selective noradrenergic denervation on noradrenaline content and [3H]dopamine release in rat nucleus accumbens slices. Russell VA; Lamm MC; Allin R; de Villiers AS; Searson A; Taljaard JJ Neurochem Res; 1989 Feb; 14(2):169-72. PubMed ID: 2725817 [TBL] [Abstract][Full Text] [Related]
11. Quantification of presynaptic alpha 2-adrenoceptors in rat brain after short-term DSP-4 lesioning. Heal DJ; Butler SA; Prow MR; Buckett WR Eur J Pharmacol; 1993 Nov; 249(1):37-41. PubMed ID: 7506666 [TBL] [Abstract][Full Text] [Related]
12. Facilitation of shock-induced fighting in the rat after DSP-4, a selective noradrenergic neurotoxin. Mogilnicka E; Dooley DJ; Boissard CG; Delini-Stula A Pharmacol Biochem Behav; 1983 Apr; 18(4):625-8. PubMed ID: 6602990 [TBL] [Abstract][Full Text] [Related]
13. Depletion of brain norepinephrine with DSP-4 does not alter acquisition or performance of a radial-arm maze task. Chrobak JJ; DeHaven DL; Walsh TJ Behav Neural Biol; 1985 Jul; 44(1):144-50. PubMed ID: 3834919 [TBL] [Abstract][Full Text] [Related]
14. Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats. Kask A; Harro J; Tuomaine P; Rägo L; Männistö PT Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):267-72. PubMed ID: 9050022 [TBL] [Abstract][Full Text] [Related]
15. Alterations in drug induced catalepsy and post-decapitation convulsions following brain and spinal cord depletion of norepinephrine by the neurotoxin DSP-4. Asin KE; Wirtshafter D; Fibiger HC Life Sci; 1982 May; 30(18):1531-6. PubMed ID: 7200562 [TBL] [Abstract][Full Text] [Related]
16. Region- and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents. Fornai F; Bassi L; Torracca MT; Alessandrì MG; Scalori V; Corsini GU Neurodegeneration; 1996 Sep; 5(3):241-9. PubMed ID: 8910902 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of DSP-4 on noradrenaline axons in cerebral cortex and hypothalamus may reflect heterogeneity of noradrenaline uptake sites. Zaczek R; Fritschy JM; Culp S; De Souza EB; Grzanna R Brain Res; 1990 Jul; 522(2):308-14. PubMed ID: 2171719 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals. Fritschy JM; Grzanna R Neuroscience; 1989; 30(1):181-97. PubMed ID: 2747911 [TBL] [Abstract][Full Text] [Related]
19. Noradrenaline and dopamine interaction in rat brain during development. Ponzio F; Hallman H; Jonsson G Med Biol; 1981 Jun; 59(3):161-9. PubMed ID: 6796787 [TBL] [Abstract][Full Text] [Related]
20. Response of central monoamine neurons following an early neurotoxic lesion. Jonsson G; Hallman H Bibl Anat; 1982; (23):76-92. PubMed ID: 6291505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]